Login / Signup

Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy.

Scott K AdneyJohn J MillichapJean-Marc DeKeyserTatiana AbramovaChristopher H ThompsonAlfred L George
Published in: Annals of clinical and translational neurology (2020)
Our study demonstrates the value of conducting functional analyses of SCN2A variants of unknown significance to establish pathogenicity and genotype-phenotype correlations. We also show concordance of in vitro pharmacology using heterologous cells with the drug response observed clinically in a case of SCN2A-associated epilepsy.
Keyphrases